Screener
Atea Pharmaceuticals, Inc. AVIR Q1 2025 earnings
Reported May 12, 2025 · After market close
EPS-$0.40Beat by $0.16
EPS estimate-$0.56
Next report
Nov 11, 2026 (in 2 months)Revenue estimate$50.4M
EPS estimate-$0.51
Versus estimates
Diluted EPS
FAQ
- When did Atea Pharmaceuticals, Inc. report Q1 2025 earnings?
- Atea Pharmaceuticals, Inc. (AVIR) reported Q1 2025 earnings on May 12, 2025 after market close.
- What were Atea Pharmaceuticals, Inc.'s Q1 2025 revenue and EPS?
- Atea Pharmaceuticals, Inc. reported eps of $-0.40 for Q1 2025.
- Did Atea Pharmaceuticals, Inc. beat estimates in Q1 2025?
- EPS beat the consensus estimate of $-0.56 by $0.16.
- How did Atea Pharmaceuticals, Inc.'s Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 46.7% from $-0.75.
- Where can I find Atea Pharmaceuticals, Inc.'s Q1 2025 SEC filings?
- You can read the 8-K earnings release (0001193125-25-117809) and the 10-Q periodic report (0000950170-25-069367) directly on SEC EDGAR. The filing index links above go to sec.gov.
